Publications by authors named "Shiho Ueda"

Claim this Profile
S
Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain.
Kana Hasegawa, Shunya Ikeda, Moto Yaga, Kouki Watanabe, Rika Urakawa, Shiho Ueda

Sci Transl Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogenic transformation of NIH/3T3 cells by the overexpression of L-type amino acid transporter 1, a promising anti-cancer target.
Natsumi Hayashi, Akitaka Yamasaki, Shiho Ueda, Shogo Okazaki, Yoshiya Ohno

Oncotarget· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS-mutated human colorectal cancer cells.
Yuta Hara, Yushi Minami, Soshi Yoshimoto, Natsumi Hayashi, Akitaka Yamasaki, Shiho Ueda

Cancer Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel functional anti-HER3 monoclonal antibodies with potent anti-cancer effects on various human epithelial cancers.
Kouki Okita, Shogo Okazaki, Shinya Uejima, Erina Yamada, Hiroki Kaminaka, Shiho Ueda

Oncotarget· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumor effects of mAb against L-type amino acid transporter 1 (LAT1) bound to human and monkey LAT1 with dual avidity modes.
Shiho Ueda, Hidemi Hayashi, Takako Miyamoto, Shinya Abe, Kana Hirai

Cancer Sci· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1.
Yuta Hara, Ryota Torii, Shiho Ueda, Erina Kurimoto, Eri Ueda

Cancer Sci· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment.
Malinee Thanee, Watcharin Loilome, Anchalee Techasen, Eiji Sugihara, Shogo Okazaki, Shiho Ueda

Cancer Sci· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an ErbB4 monoclonal antibody that blocks neuregulin-1-induced ErbB4 activation in cancer cells.
Shogo Okazaki, Fumi Nakatani, Kazue Masuko, Kenji Tsuchihashi, Shiho Ueda

Biochem Biophys Res Commun· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sip1, an AP-1 accessory protein in fission yeast, is required for localization of Rho3 GTPase.
Yang Yu, Cuifang Li, Ayako Kita, Yuta Katayama, Koji Kubouchi, Shiho Ueda

PLoS One· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NIH3T3 cells overexpressing CD98 heavy chain resist early G1 arrest and apoptosis induced by serum starvation.
Kaori Hara, Shiho Ueda, Yoshiya Ohno, Toshiyuki Tanaka, Hideki Yagi

Cancer Sci· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis